<DOC>
	<DOCNO>NCT02459574</DOCNO>
	<brief_summary>A streamlined AF ablation procedure do without PV map daycase effective anti-arrhythmic drug reduce hospital episode recurrent atrial fibrillation .</brief_summary>
	<brief_title>Ablation Verses Anti-arrhythmic Therapy Reducing All Hospital Episodes From Recurrent Atrial Fibrillation</brief_title>
	<detailed_description>AVATAR-AF multicentre , randomise control study compare streamline AVATAR-protocol ablation procedure anti-arrhythmic therapy patient document paroxysmal AF consider fail current strategy AF . A secondary control arm also compare AVATAR-protocol conventional AF ablation . 300 patient prior anti-arrhythmic , 'pill-in-pocket ' take regular anti-arrhythmics randomise 1:1:1 manner treatment strategy either AVATAR-protocol ablation , anti-arrhythmic therapy conventional AF ablation followed-up 1 year .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Sotalol</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<mesh_term>Flecainide</mesh_term>
	<mesh_term>Propafenone</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>1 . Documented paroxysmal atrial fibrillation 2 . Modification initiation antiarrhythmic agent require symptom control 3 . Males female eighteen ( 18 ) eighty ( 80 ) year age 4 . Suitable candidate catheter ablation 5 . Signed informed consent 1 . Contraindication catheter ablation 2 . No carer enable daycase discharge 3 . Arrhythmias AF document unless curative ablation ( eg . atrial flutter ) 4 . No documentation sinus rhythm within 3 month 5 . Valvular coronary heart disease need regular follow 6 . EF &lt; 45 % moderate/severe LV dysfunction 7 . Active gastrointestinal disease 8 . Renal failure creatinine &gt; 200 μmol/L dialysis 9 . Active fever infection 10 . Life expectancy shorter trial 11 . Allergy contrast 12 . Severe cerebrovascular disease 13 . Bleeding clot disorder inability receive heparin 14 . Uncontrolled diabetes ( HbA1c ≥73 mmol/mol HbA1c ≤64 mmol/mol Fasting Blood Glucose ≥9.2 mmol/L ) 15 . Serum Potassium [ K+ ] &lt; 3.5 mmol/L &gt; 5.0 mmol/L 16 . Malignancy need surgery , chemotherapy radiotherapy 17 . Pregnancy woman childbearing potential use highly effective method contraception 18 . Must previous ( 4 week prior screen ) current participation another clinical trial investigational drug investigational device 19 . Unable give inform consent 20 . Uncontrolled thyroid disease define abnormal thyroid function test cause cardiac manifestation within last 6mths 21 . Unable attend follow visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Heart Failure</keyword>
</DOC>